Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-०.२१%
१,०९१.५१
-२.३०
-०.२१%
—१,०९३.८११,०९६.५२१,१००.२२१,०९१.५१——
SIXC
Communications
SIXC
Communications
SIXC
+०.२२%
६१०.११
+१.३४
+०.२२%
—६०८.७७६०८.७७६१२.९७६०८.७७——
SIXE
Energy
SIXE
Energy
SIXE
-१.३४%
१,२३७.९८
-१६.८३
-१.३४%
—१,२५४.८११,२५३.०११,२५३.८७१,२२६.३३——
SIXI
Industrials
SIXI
Industrials
SIXI
-०.९३%
१,७४४.७१
-१६.४०
-०.९३%
—१,७६१.१११,७६४.२७१,७६६.८८१,७४४.७१——
SIXM
Financials
SIXM
Financials
SIXM
-०.३७%
६४०.१८
-२.४०
-०.३७%
—६४२.५८६४४.८७६४८.४८६४०.१८——
SIXR
Staples
SIXR
Staples
SIXR
-०.१८%
८४९.५८
-१.५५
-०.१८%
—८५१.१३८५५.६६८५८.७५८४५.५६——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-०.२३%
२१७.४८
-०.५०
-०.२३%
—२१७.९८२१७.९८२१८.६५२१६.८८——
SIXT
Technology
SIXT
Technology
SIXT
+१.५२%
३,२६०.६९
+४८.८६
+१.५२%
—३,२११.८३३,२२७.२१३,२६८.३८३,२२६.५५——
SIXU
Utilities
SIXU
Utilities
SIXU
-०.६९%
९४२.४५
-६.५३
-०.६९%
—९४८.९८९४८.५८९५७.८३९४१.९७——
SIXV
Health care
SIXV
Health care
SIXV
-०.५२%
१,४६६.८०
-७.७२
-०.५२%
—१,४७४.५२१,४७९.०३१,४८१.०४१,४६६.८०——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+०.२२%
२,३९७.५०
+५.३८
+०.२२%
—२,३९२.१२२,३९६.९५२,४२१.२२२,३८२.३२——
NOVA:FRA
Novo Nordisk A/S
€ ३६.०४
+४.४६%
(+१.५४) 1D
अप्रिल ३०, २२:००:०० GMT+२  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for NOVA...
Open
€ ३४.१८
High
€ ३६.५०
Low
€ ३४.१८
Mkt. cap
१.५० खरब
Avg. vol.
३.०२ हजार
Volume
३.३९ हजार
52-wk high
€ ७१.८०
52-wk low
€ ३०.४५
No. of employees
६९ हजार
News stories
From sources across the web
Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28.1% of its shares and a majority of its voting shares. Novo Nordisk manufactures and markets pharmaceutical products and services, specifically diabetes and obesity medications and devices. Novo Nordisk employs more than 48,000 people globally, and markets its products in 168 countries. The corporation was created in 1989, through a merger of two Danish companies, which date back to the 1920s. Novo Nordisk is a full member of the European Federation of Pharmaceutical Industries and Associations. The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo Nordisk was named the most sustainable company in the world by the business magazine Corporate Knights, while spin-off company Novozymes was named fourth. It is a leader in the FTSE4Good Index, and the only European company in the top ten. Novo Nordisk is the largest pharmaceutical company in Denmark. Wikipedia
About Novo Nordisk A/S
CEOMaziar Mike Doustdar
Employees६९.२ हजार
Founded१९२३ डिसेम्बर २१
HeadquartersBagsværd, Capital Region of Denmark, डेनमार्क
Sector-
Websitenovonordisk.com
Previous reportsAll values in DKK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in DKK
२०२५ मार्च
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
Revenue
७८.०९ अरब
७६.८६ अरब
७४.९८ अरब
७९.१४ अरब
Cost of goods sold
१२.८९ अरब
१२.८५ अरब
१४.४७ अरब
१४.१७ अरब
Cost of revenue
१२.८९ अरब
१२.८५ अरब
१४.४७ अरब
१४.१७ अरब
Research and development expenses
१०.३१ अरब
११.६९ अरब
११.४९ अरब
१२.६७ अरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१६.११ अरब
१८.८५ अरब
१५.७६ अरब
१७.१४ अरब
Operating expense
२६.४१ अरब
३०.५६ अरब
२७.२५ अरब
२९.७३ अरब
Total operating expenses
३९.३० अरब
४३.४१ अरब
४१.७२ अरब
४३.९० अरब
Operating income
३८.७९ अरब
३३.४५ अरब
३३.२५ अरब
३५.२४ अरब
Other non operating income
-
-
१.५३ अरब
-२४.१० करोड
EBT including unusual items
३७.०३ अरब
३३.८० अरब
२५.५२ अरब
३४.१८ अरब
EBT excluding unusual items
३७.०३ अरब
३३.८० अरब
३५.०९ अरब
३७.६२ अरब
Income tax expense
८.०० अरब
७.३० अरब
५.५१ अरब
७.२९ अरब
Effective tax rate
२१.६०%
२१.६०%
२१.६०%
२१.३४%
Other operating expenses
-१.४० करोड
२.३० करोड
-
-८.१० करोड
Net income
२९.०३ अरब
२६.५० अरब
२०.०१ अरब
२६.८९ अरब
Net profit margin
३७.१८%
३४.४८%
२६.६८%
३३.९८%
Earnings per share
६.५३
५.९६
४.५०
६.०४
Interest and investment income
३.४२ अरब
५.३१ अरब
३०.७० करोड
४.४१ अरब
Interest expense
-३.८६ अरब
-४.९६ अरब
-
-४.९७ अरब
Net interest expenses
-४३.३० करोड
३५.६० करोड
३०.७० करोड
-५६.०० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
४२.६२ अरब
३७.६५ अरब
३६.४९ अरब
३६.६६ अरब
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer